Dr. Abdullah Mohammed Al Salti

Dr. Abdullah is a Senior Consultant Neurologist and Neuromuscular Specialist with 24 years of experience, and one of Oman's foremost leaders in the field — former President of the Oman Neurology Society (2021–2024) and former Head of the Neurology Department at Khoula Hospital, the country's national neuroscience referral center.

Dr. Abdullah earned his MD from Sultan Qaboos University in 2002 and obtained Membership of the Royal College of Physicians of the UK (MRCP) in 2006 after internal medicine residency at the Royal Hospital. He then completed his full Neurology residency at McGill University, Montreal, Canada (2008–2013), earning Fellowship of the Royal College of Physicians of Canada (FRCPC), followed by a subspecialty Fellowship in Neuromuscular Disorders and Electromyography at McGill (2014) and certification of the Canadian Society of Clinical Neurophysiology (CSCN).

Returning to Oman, he served as Senior Consultant and Deputy Head of Neurology at the Royal and Khoula Hospitals (2015–2017), then as Head of the Neurology Department at Khoula Hospital (2017–2022), where he established the department's Neurology Board of Management and founded three specialized units — Neurophysiology, Multiple Sclerosis, and Epilepsy — strengthened stroke units across Khoula, Sohar, Nizwa, and Salalah, introduced new neurological therapies and diagnostic technologies, and developed national clinical guidelines. Since 2023 he has served as Assistant Director General for Medical Affairs at the Directorate General of Khoula Hospital, and he sees patients at Muscat Private Hospital. He is an Adjunct Senior Lecturer at Sultan Qaboos University, chairs and serves on multiple OMSB committees, and has represented Omani neurology in the World Federation of Neurology, the PAN Arab Neurology Association, and the Gulf Neurology Society.

Dr. Abdullah's particular passion is neuromuscular medicine — from myasthenia gravis and muscular dystrophies to ALS and rare genetic diseases — where precise electrodiagnosis (EMG) and today's rapidly advancing immunotherapies and gene therapies are transforming what is possible for patients.